Albemarle(GB:0HC7)
$96.27+1.77 (+1.87%)
GB:0HC7
Albemarle financials statements
$96.27
At close:+1.77 (+1.87%)
Albemarle (0HC7) Financial Statements
4 Followers
Albemarle Financial Overview
Albemarle's market cap is currently $11.20B. The company's EPS TTM is $4.36; its P/E ratio is 22.01; and it has a dividend yield of 1.71%. Albemarle is estimated to report earnings on February 17, 2027, and the estimated EPS forecast is $1.47. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 5.14B | $ 5.38B | $ 9.62B | $ 7.32B | $ 3.33B |
| Gross Profit | $ 671.62M | $ 60.24M | $ 1.20B | $ 3.09B | $ 1.01B |
| Operating Income | $ 93.79M | $ -636.01M | $ 241.12M | $ 2.50B | $ 532.66M |
| EBITDA | $ 558.00M | $ -294.13M | $ 2.65B | $ 3.63B | $ 544.86M |
| Net Income | $ -510.63M | $ -1.18B | $ 1.57B | $ 2.69B | $ 123.67M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.62B | $ 1.19B | $ 889.90M | $ 1.50B | $ 439.27M |
| Total Assets | $ 16.37B | $ 16.61B | $ 18.27B | $ 15.46B | $ 10.97B |
| Total Debt | $ 3.30B | $ 3.62B | $ 4.28B | $ 3.32B | $ 2.52B |
| Net Debt | $ 1.68B | $ 2.42B | $ 3.39B | $ 1.82B | $ 2.08B |
| Total Liabilities | $ 6.59B | $ 6.41B | $ 8.61B | $ 7.27B | $ 5.17B |
| Stockholders' Equity | $ 9.53B | $ 9.96B | $ 9.41B | $ 7.98B | $ 5.63B |
| Cash Flow | |||||
| Free Cash Flow | $ 692.47M | $ -992.65M | $ -827.96M | $ 646.20M | $ -609.41M |
| Operating Cash Flow | $ 1.28B | $ 687.88M | $ 1.33B | $ 1.91B | $ 344.26M |
| Investing Cash Flow | $ -146.01M | $ -1.58B | $ -2.56B | $ -1.42B | $ -666.59M |
| Financing Cash Flow | $ -834.19M | $ 1.24B | $ 623.91M | $ 611.89M | $ 50.21M |
Currency in USD
